China National Medicines Corporation Ltd.’s Net Profit Rose 10% in First Quarter of 2023

China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (600511.SH) reported a net profit of 450.4 million yuan in the first quarter of 2023, up 10% year-on-year.

Meanwhile, the company posted 11.2 billion yuan in revenue, up 1.5% year-on-year.

At the end of the reporting period, it had 30 billion yuan in total assets and 13.7 billion yuan in total liabilities, with a liability-to-asset ratio of 45.6%.